UBS Group’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.9K | Sell |
|
|||||
|
2025
Q1 | $99.4K | Buy |
|
|||||
|
2024
Q4 | $88.3K | Buy |
|
|||||
|
2024
Q3 | $98.6K | Buy |
|
|||||
|
2024
Q2 | $119K | Hold |
|
|||||
|
2024
Q1 | $224K | Sell |
|
|||||
|
2023
Q4 | $111K | Sell |
|
|||||
|
2023
Q3 | $92.1K | Hold |
|
|||||
|
2023
Q2 | $152K | Hold |
|
|||||
|
2023
Q1 | $130K | Buy |
|
|||||
|
2022
Q4 | $89.6K | Buy |
|
|||||
|
2022
Q3 | $57K | Sell |
|
|||||
|
2022
Q2 | $69K | Sell |
|
|||||
|
2022
Q1 | $100K | Buy |
|
|||||
|
2021
Q4 | $105K | Buy |
|
|||||
|
2021
Q3 | $86K | Sell |
|
|||||
|
2021
Q2 | $121K | Buy |
|
|||||
|
2021
Q1 | $39K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2K | Sell |
|
|||||
|
2020
Q2 | $19K | Buy |
|